LOVD - Variant listings for BRCA1

Warning Please note that this overview may not be complete, as variants with unknown effect to the phenotype are left out.

27 entries
entries per page

Exon Hide Exon column Descending
Ascending
DNA change   Descending
Ascending
BIC DNA change Hide BIC DNA change column Descending
Ascending
Protein change Hide Protein change column Descending
Ascending
Posterior P Hide Posterior P column Descending
Ascending
IARC Class Hide IARC Class column Descending
Ascending
Key Observational Reference Hide Key Observational Reference column Descending
Ascending
Prior P reference Hide Prior P reference column Descending
Ascending
Missense analysis Prior P Hide Missense analysis Prior P column Descending
Ascending
Splicing prior P Hide Splicing prior P column Descending
Ascending
Other Prior P Hide Other Prior P column Descending
Ascending
Combined prior P Hide Combined prior P column Descending
Ascending
Segregation LR Hide Segregation LR column Descending
Ascending
Pathology LR Hide Pathology LR column Descending
Ascending
Sum Family LR Hide Sum Family LR column Descending
Ascending
Co-occurrence LR Hide Co-occurrence LR column Descending
Ascending
case-control LR Hide case-control LR column Descending
Ascending
Product of LRs Hide Product of LRs column Descending
Ascending
Comments Hide Comments column Descending
Ascending
DB-ID Hide DB-ID column Descending
Ascending
3 c.133A>C 252A>C p.K45Q 0.00080 1 - Not pathogenic or of no clinical significance Sweet et al., 2010 Tavtigian et al. 2008 0.03 0.04 0.00 0.03 - 0.0193 1.344 - - 0.02594 - BRCA1_00116
7 c.425C>A 544C>A p.P142H 0.00000 1 - Not pathogenic or of no clinical significance Chenevix-Trench et al. 2006 Tavtigian et al. 2008 0.02 0.01 0.00 0.02 1.7 0.0069 - 0.0043 - 5.04390E-5 - BRCA1_00025
11 c.736T>G 855T>G p.L246V 0.00000 1 - Not pathogenic or of no clinical significance Tavtigian et al. 2006 Tavtigian et al. 2008 0.02 0.01 0.00 0.02 - - - 2.60E-05 - 2.60000E-5 - BRCA1_00017
11 c.1067A>G 1186A>G p.Q356R 0.00000 1 - Not pathogenic or of no clinical significance Tavtigian et al. 2006 Tavtigian et al. 2008 0.02 0.01 0.00 0.02 - - - <1e-10 - <1e-10 - BRCA1_00014
11 c.1487G>A 1606G>A p.R496H 0.00000 1 - Not pathogenic or of no clinical significance Tavtigian et al. 2006 Tavtigian et al. 2008 0.02 0.01 0.00 0.02 - - - 9.20E-05 - 9.20000E-5 - BRCA1_00018
11 c.2077G>A 2196G>A p.D693N 0.00000 1 - Not pathogenic or of no clinical significance Tavtigian et al. 2006 Tavtigian et al. 2008 0.02 0.01 0.00 0.02 - - - 1.00000E-10 - 1.00000E-10 - BRCA1_00004
11 c.2315T>C 2434T>C p.V772A 0.00000 1 - Not pathogenic or of no clinical significance Tavtigian et al. 2006 Tavtigian et al. 2008 0.02 0.01 0.00 0.02 - - - 9.40E-06 - 9.40000E-6 - BRCA1_00024
11 c.2412G>C 2531G>C p.Q804H 0.00045 1 - Not pathogenic or of no clinical significance Chenevix-Trench et al. 2006 Tavtigian et al. 2008 0.02 0.01 0.00 0.02 1.12 0.0087 - 2.244 - 0.02187 - BRCA1_00027
11 c.2458A>G 2577A>G p.K820E 0.00000 1 - Not pathogenic or of no clinical significance Tavtigian et al. 2006 Tavtigian et al. 2008 0.02 0.01 0.00 0.02 - - - <1e-10 - <1e-10 - BRCA1_00005
11 c.2521C>T 2640C>T p.R841W 0.00000 1 - Not pathogenic or of no clinical significance Goldgar et al. 2004 Tavtigian et al. 2008 0.02 0.01 0.00 0.02 4.00E-09 - - 0.028 - 1.12000E-10 - BRCA1_00003
11 c.2566T>C 2685T>C p.Y856H 0.00018 1 - Not pathogenic or of no clinical significance Tavtigian et al. 2006 Tavtigian et al. 2008 0.02 0.01 0.00 0.02 - - - 8.80E-03 - 0.0088 - BRCA1_00006
11 c.2612C>T 2731C>T p.P871L 0.00000 1 - Not pathogenic or of no clinical significance Tavtigian et al. 2006 Tavtigian et al. 2008 0.02 0.02 0.00 0.02 - - - <1e-10 - <1e-10 - BRCA1_00007
11 c.3022A>G 3141A>G p.M1008V 0.00000 1 - Not pathogenic or of no clinical significance Tavtigian et al. 2006 Tavtigian et al. 2008 0.02 0.01 0.00 0.02 - - - <1e-10 - <1e-10 - BRCA1_00019
11 c.3024G>A 3143G>A p.M1008I 0.00000 1 - Not pathogenic or of no clinical significance Tavtigian et al. 2006 Tavtigian et al. 2008 0.02 0.01 0.00 0.02 - - - 9.60E-07 - 9.60000E-7 - BRCA1_00020
11 c.3113A>G 3232A>G p.E1038G 0.00000 1 - Not pathogenic or of no clinical significance Tavtigian et al. 2006 Tavtigian et al. 2008 0.02 0.01 0.00 0.02 - - - <1e-10 - <1e-10 - BRCA1_00008
11 c.3119G>A 3238G>A p.S1040N 0.00000 1 - Not pathogenic or of no clinical significance Tavtigian et al. 2006 Tavtigian et al. 2008 0.02 0.01 0.00 0.02 - - - <1e-10 - <1e-10 - BRCA1_00015
11 c.3418A>G 3537A>G p.S1140G 0.00000 1 - Not pathogenic or of no clinical significance Tavtigian et al. 2006 Tavtigian et al. 2008 0.02 0.01 0.00 0.02 - - - 2.90E-04 - 0.00029 - BRCA1_00009
11 c.3463G>C 3582G>C p.D1155H 0.00000 1 - Not pathogenic or of no clinical significance Chenevix-Trench et al. 2006 Tavtigian et al. 2008 0.02 0.01 0.00 0.02 0.0025 0.139 - - - 0.00035 - BRCA1_00028
11 c.3548A>G 3667A>G p.K1183R 0.00000 1 - Not pathogenic or of no clinical significance Tavtigian et al. 2006 Tavtigian et al. 2008 0.02 0.01 0.00 0.02 - - - <1e-10 - <1e-10 - BRCA1_00010
11 c.3748G>A 3867G>A p.E1250K 0.00000 1 - Not pathogenic or of no clinical significance Tavtigian et al. 2006 Tavtigian et al. 2008 0.02 0.01 0.00 0.02 - - - 1.00E-05 - 1.00000E-5 - BRCA1_00021
11 c.4039A>G 4158A>G p.R1347G 0.00000 1 - Not pathogenic or of no clinical significance Tavtigian et al. 2006 Tavtigian et al. 2008 0.02 0.01 0.00 0.02 - - - <1e-10 - <1e-10 - BRCA1_00011
15 c.4535G>T 4654G>T p.S1512I 0.00000 1 - Not pathogenic or of no clinical significance Tavtigian et al. 2006 Tavtigian et al. 2008 0.02 0.01 0.00 0.02 - - - <1e-10 - <1e-10 - BRCA1_00016
15 c.4600G>A 4719G>A p.V1534M 0.00010 1 - Not pathogenic or of no clinical significance Chenevix-Trench et al. 2006 Tavtigian et al. 2008 0.02 0.01 0.00 0.02 0.0086 0.139 - 4.02 - 0.00481 - BRCA1_00029
15 c.4636G>A 4755G>A p.D1546N 0.00011 1 - Not pathogenic or of no clinical significance Tavtigian et al. 2006 Tavtigian et al. 2008 0.02 0.01 0.00 0.02 - - - 5.60E-03 - 0.0056 - BRCA1_00022
16 c.4837A>G 4956A>G p.S1613G 0.00000 1 - Not pathogenic or of no clinical significance Tavtigian et al. 2006 Tavtigian et al. 2008 0.02 0.01 0.00 0.02 - - - <1e-10 - <1e-10 - BRCA1_00012
Exon Hide Exon column Descending
Ascending
DNA change   Descending
Ascending
BIC DNA change Hide BIC DNA change column Descending
Ascending
Protein change Hide Protein change column Descending
Ascending
Posterior P Hide Posterior P column Descending
Ascending
IARC Class Hide IARC Class column Descending
Ascending
Key Observational Reference Hide Key Observational Reference column Descending
Ascending
Prior P reference Hide Prior P reference column Descending
Ascending
Missense analysis Prior P Hide Missense analysis Prior P column Descending
Ascending
Splicing prior P Hide Splicing prior P column Descending
Ascending
Other Prior P Hide Other Prior P column Descending
Ascending
Combined prior P Hide Combined prior P column Descending
Ascending
Segregation LR Hide Segregation LR column Descending
Ascending
Pathology LR Hide Pathology LR column Descending
Ascending
Sum Family LR Hide Sum Family LR column Descending
Ascending
Co-occurrence LR Hide Co-occurrence LR column Descending
Ascending
case-control LR Hide case-control LR column Descending
Ascending
Product of LRs Hide Product of LRs column Descending
Ascending
Comments Hide Comments column Descending
Ascending
DB-ID Hide DB-ID column Descending
Ascending
16 c.4883T>C 5002T>C p.M1628T 0.00000 1 - Not pathogenic or of no clinical significance Tavtigian et al. 2006 Tavtigian et al. 2008 0.02 0.01 0.00 0.02 - - - 1.60E-04 - 0.00016 - BRCA1_00013
16 c.4956G>A 5075G>A p.M1652I 0.00001 1 - Not pathogenic or of no clinical significance Osorio et al. 2007 Tavtigian et al. 2008 0.03 0.01 0.00 0.03 - 0.00268 0.18 - - 0.00048 - BRCA1_00107
1 - 27

Legend: [ BRCA1 full legend ]

Exon: Standard BRCA1 (or BRCA2) exon numbering. DNA change: Sequence variant name in HGVS cDNA sequence based nomenclature. BIC DNA change: Sequence variant name in older BIC nomenclature. Protein change: Sequence variant name in HGVS protein amino acid sequence based nomenclature. Posterior P: Posterior probability in favor of pathogenicity. IARC Class: Qualitative classification in the 5-grade IARC classification scheme. Key Observational Reference: Key Observational Reference Prior P reference: Literature source of the sequence analysis based prior probability in favor of pathogenicity used in the integrated evaluation displayed here. Missense analysis Prior P: This prior probability estimate combines position in the protein with an Align-GVGD based evaluation of missense substitutions that fall in the protein's key functional domains. Splicing prior P: This prior probability estimate evaluates the sequence variant's probability to damage a splice donor, damage a splice acceptor, or create a de novo splice donor. Other Prior P: Custom Priors other than missense or splice (short legend) Combined prior P: The combined prior probability in favor of pathogenicity. is a combination of the missense analysis prior probability and the splicing analysis prior probability. Generally, it is the higher of the two sequence analysis-based prior probabilities. Segregation LR: The likelihood ratio based on segregation analysis. Pathology LR: The likelihood ratio based on tumor pathology and/ or tumor immunohistochemistry. Sum Family LR: The likelihood ratio based on an analysis of the severity of summary family histories of breast and/ or ovarian cancer. Co-occurrence LR: The likelihood ratio based on the frequency of co-occurrence between the variant of interest and clearly pathogenic variants in the same gene. case-control LR: case-control likelihood ratios from iCOGS (short legend) Product of LRs: The product of all of the likelihood ratios Comments: alternate references, caveats, and additional information. BRCA1 DB-ID: Database IDentifier; When available, links to OMIM ID's are provided.